🧬 ICD-10-CM E22.2 β€” Syndrome of Inappropriate Secretion of Antidiuretic Hormone

Billable Code Confirmed

ICD-10-CM E22.2 is a valid, billable 4-character ICD-10-CM code for FY2026. The 4 characters define the category and subcategory perfectly. No additional characters are required.

Non-Billable Parent Codes β€” Never Submit These

  • ❌ E22 β€” 3-character header β€” Missing specification of the exact hyperfunctioning pituitary syndrome.

Always submit E22.2 (all 4 characters) when Syndrome of Inappropriate Antidiuretic Hormone is documented.

Clinical Context: Fluid and Electrolyte Imbalance

ICD-10-CM E22.2 captures the pathological state where the body produces too much antidiuretic hormone (ADH), leading to water retention and dilutional hyponatremia. Identifying this code accurately is crucial as it distinguishes a primary endocrine/hormonal issue from other causes of hyponatremia.

Code Classification

ICD-10-CM Diagnosis Code β€” wRVU, assistant payable, and global period fields are not applicable. See CPT Procedural Crosswalk and ICD-10-PCS Crosswalk sections for associated procedural billing.


πŸ” Code Description

ICD-10-CM E22.2 classifies Syndrome of inappropriate secretion of antidiuretic hormone (SIADH). This code represents a condition where the posterior pituitary gland or an ectopic source secretes excessive amounts of antidiuretic hormone, causing the kidneys to retain water inappropriately and lowering blood sodium levels 1.

It is often associated with malignancies (especially small cell lung cancer), central nervous system disorders, and pulmonary diseases, or it can be drug-induced. Accurate coding relies on distinguishing SIADH from isolated hyponatremia (which maps to E87.1), though they may be coded together if the criteria for both are distinctly met and not mutually exclusive based on the primary etiology2.


🌳 Code Tree / Hierarchy

E22 Hyperfunction of pituitary gland ❌ Non-billable
β”‚
β”œβ”€β”€ E22.0 Acromegaly and pituitary gigantism βœ… Billable
β”œβ”€β”€ E22.1 Hyperprolactinemia βœ… Billable
β”œβ”€β”€ E22.2 Syndrome of inappropriate secretion of antidiuretic hormone β—€ THIS CODE βœ… Billable
β”œβ”€β”€ E22.8 Other hyperfunction of pituitary gland βœ… Billable
└── E22.9 Hyperfunction of pituitary gland, unspecified βœ… Billable

Documentation Specificity

SIADH is a definitive diagnosis. If a provider only documents β€œhyponatremia,” you must code E87.1 instead. A query is recommended if the clinical indicators (low serum osmolality, high urine osmolality) strongly suggest SIADH but it is not explicitly documented.


βœ… Includes

The following clinical terms and scenarios map to E22.2 when documented:

  • Syndrome of inappropriate antidiuretic hormone
  • SIADH
  • Inappropriate secretion of ADH

❌ Excludes

Excludes 1 β€” Cannot Be Coded Simultaneously with E22.2

CodeDescriptionNote
E23.2Diabetes insipidusDiabetes insipidus represents a deficiency or resistance to ADH (water loss), which is pathophysiologically the exact opposite of SIADH (water retention)1.

Excludes 1 Violation Risk

A coder might mistakenly try to code both conditions if a patient has fluctuating sodium levels or a biphasic response after pituitary surgery. Ensure you are coding the current, active phase of the disease as supported by the physician’s final diagnosis.

Excludes 2 β€” May Be Coded in Addition if Separately Present

CodeDescriptionNote
E87.1Hypo-osmolality and hyponatremiaHyponatremia is the primary manifestation of SIADH. Both can be coded together if the hyponatremia requires independent, complex management (like hypertonic saline administration) outside the baseline SIADH treatment, per facility guidelines3.

πŸ“‹ Clinical Overview

Etiology and Phenotype Distinction

SIADH is not a single disease but rather a syndrome caused by an underlying issue. Identifying the root cause is crucial for correct comprehensive coding.

FeatureE22.2 β€” SIADHE87.1 β€” Hyponatremia
Underlying MechanismExcess ADH causing water retentionVarious (e.g., fluid overload, salt loss, diuretics)
Key Lab FindingLow serum sodium WITH high urine osmolalityLow serum sodium
Primary TreatmentFluid restriction, treating underlying causeSaline infusion, diuresis, or fluid restriction

CDI Query Trigger β€” Underlying Cause

SIADH is often secondary to a malignancy, CNS trauma, or medication. Always query the provider to link the SIADH to its underlying etiology (e.g., small cell lung cancer) if not explicitly stated, as both should be coded to fully capture patient complexity.

Manifestations & Symptom Burden

Common manifestations or clinical indicators of SIADH include:

  • Neurological symptoms: Confusion, lethargy, seizures, or coma (due to cerebral edema from hyponatremia).
  • Gastrointestinal symptoms: Nausea, vomiting, and anorexia.
  • Muscle symptoms: Weakness, cramps, and diminished reflexes.

Coding Manifestations

Always code the underlying etiology (if known) and the documented manifestations to fully capture the patient’s complexity. Examples include:

  • C34.90 β€” Malignant neoplasm of unspecified part of bronchus or lung
  • R56.9 β€” Unspecified convulsions
  • R41.0 β€” Disorientation, unspecified

πŸ’° HCC Risk Adjustment (CMS-HCC v28)

FieldDetail
CMS-HCC Model Versionv28 (2024-2025 Implementation)
HCC Assignment❌ Not HCC-Mapped
HCC CategoryN/A
RAF CoefficientN/A

E22.2 does not directly map to an HCC under v28.

Capture Annually

Even though this code is not HCC-mapped, the underlying conditions that cause SIADH (like malignancies or severe pulmonary diseases) often are HCC-mapped. Always ensure the root cause is captured annually.


πŸ₯ DRG Assignment

MDC 10 β€” Endocrine, Nutritional and Metabolic Diseases

DRGTitleEst. Relative Weight*
DRG 643Endocrine Disorders with MCC~1.63
DRG 644Endocrine Disorders with CC~0.99
DRG 645Endocrine Disorders without CC/MCC~0.67

Approximate. Verify against IPPS FY2026 Final Rule tables.

Sequencing and Complications

When a patient is admitted primarily for the treatment of SIADH, E22.2 is sequenced as the principal diagnosis. When E22.2 is present on admission or develops during the stay as a secondary diagnosis, it acts as a CC (Complication and Comorbidity), which can increase the MS-DRG weight.


Endocrine and Fluid Imbalance Variants

CodeDescription
E22.2Syndrome of inappropriate secretion of antidiuretic hormone ← This Code
E23.2Diabetes insipidus (Excludes1)
E87.1Hypo-osmolality and hyponatremia (Excludes2)

πŸ› οΈ Commonly Associated CPT Codes (Inpatient/Profee)

Inpatient Setting Context

Management of SIADH in the inpatient setting typically involves critical care or complex E/M services due to the risk of severe neurological sequelae from hyponatremia.

CPT CodeDescriptionProfee Coding Notes (Modifier 26)
99223Initial hospital inpatient care, high MDMMDM is often high due to the risk of severe complications and complex fluid management.
99291Critical care, first 30-74 minutesUsed if the patient develops seizures or coma requiring critical interventions.

NCCI Bundling Considerations

  • E/M Codes billed on the same day as minor procedures (e.g., central line placements for hypertonic saline) may require a Modifier -25 if the E/M represents a significant, separately identifiable service from the procedure.

πŸ”¬ ICD-10-PCS Crosswalk (Inpatient Procedures)

When E22.2 is an inpatient diagnosis, these PCS codes are relevant for associated inpatient procedures.

PCS SectionBody SystemRoot OperationClinical Application
3 (Administration)E (Physiological Systems and Anatomical Regions)0 (Introduction)Administration of hypertonic saline or vaptans (e.g., 3E033VZ β€” Introduction of Hormones into Peripheral Vein, Percutaneous Approach).

πŸ’Š Coding Scenarios and Examples


Scenario 1 β€” Inpatient: Small Cell Lung Cancer with SIADH

Clinical Vignette: A 68-year-old male with a known history of small cell lung cancer presents to the ED with severe confusion, nausea, and lethargy. Lab work shows a serum sodium of 112 mEq/L and high urine osmolality. The provider documents: β€œSevere hyponatremia due to SIADH secondary to small cell lung cancer.”

Principal Diagnosis:

  • E22.2 β€” Syndrome of inappropriate secretion of antidiuretic hormone (Condition treated as the primary reason for admission)

Secondary Diagnoses:

  • C34.90 β€” Malignant neoplasm of unspecified part of bronchus or lung (Underlying etiology of the SIADH)
  • E87.1 β€” Hypo-osmolality and hyponatremia (Added to capture the severe manifestation requiring hypertonic saline)
  • R41.0 β€” Disorientation, unspecified

Scenario 2 β€” CDI Query: Vague Hyponatremia

Clinical Vignette: A 75-year-old female is admitted with a serum sodium of 118 mEq/L. The discharge summary lists β€œHyponatremia.” However, the nephrology consult note details fluid restriction therapy, mentions a low serum osmolality with inappropriately concentrated urine, and states β€œlikely SIADH.”

Action / Outcome: Because β€œlikely SIADH” is documented by a consultant but not confirmed by the attending, and only β€œhyponatremia” is in the discharge summary, a CDI query is necessary to confirm if SIADH was the final diagnosis.

Query Response: Provider updates documentation to confirm: β€œSIADH is the cause of the hyponatremia.”

Corrected ICD-10-CM Coding:

  • E22.2 β€” Syndrome of inappropriate secretion of antidiuretic hormone

⚠️ Coding Pitfalls and Tips

Pitfall or Tip
❌Defaulting to Hyponatremia. Coding E87.1 instead of E22.2 when the provider explicitly documented SIADH. E22.2 is a CC and provides a more accurate clinical picture.
❌Missing the Underlying Cause. Failing to code the malignancy, head trauma, or adverse effect of a drug that caused the SIADH.
βœ…Query for Clarity. Always query if the labs point clearly to SIADH (low serum sodium, high urine sodium/osmolality, euvolemia) but the provider only writes β€œlow sodium.”
βœ…Check Excludes1. Never code E22.2 on the same claim as Diabetes Insipidus (E23.2) unless specifically directed by an updated guideline or distinct, sequential clinical event.

πŸ“š Sources

1. CMS/NCHS. ICD-10-CM Official Guidelines for Coding and Reporting, FY2026.
2. American Health Information Management Association (AHIMA). Clinical Documentation Improvement for Endocrine Disorders.
3. CMS. IPPS Final Rule FY2026 β€” MS-DRG Definitions Manual v43. MDC 10 logic tables.
4. AMA. CPT Professional Edition 2026. Evaluation and Management Section.